Join federal leadership and key stakeholders on September 28 for the virtual FDA public workshop “COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics.” The event will disseminate findings from the Federal COVID-19 Response or Countermeasures Acceleration Groups (formerly known as Operation Warp Speed) to bring relevant therapeutics to use in the next public health emergency.
Presenters will distill learnings from months of interviews, discussions, and materials review into actionable recommendations to enhance scoping, prioritizing, and communicating about research activities in a public health emergency setting. Register for the workshop to explore the findings, ask questions of the stakeholders, and share your public comments.
September 28, 2021 | 1-5:30pm Eastern
Acting Commissioner, U.S. Food & Drug Administration
Director, National Institutes of Health
Individuals and organizations may submit electronic or written comments on this public workshop by December 28, 2021 through the public docket (Docket ID: FDA-2021-N-0977). For more information about the comment submission process, please visit the Regulations.gov Frequently Asked Questions page.
This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of an award of $41,665 in federal funds (100% of the project). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA, HHS, or the U.S. Government. For more information, please visit FDA.gov.